Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001055726-25-000026
Filing Date
2025-05-13
Accepted
2025-05-13 16:00:52
Documents
73
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ino-20250331.htm   iXBRL 10-Q 1154861
2 EX-31.1 ino-33125x10qex311.htm EX-31.1 9661
3 EX-31.2 ino-3312510qex312.htm EX-31.2 10144
4 EX-32.1 ino-33125x10qex321.htm EX-32.1 8430
10 ino-20250331_g1.jpg GRAPHIC 460167
  Complete submission text file 0001055726-25-000026.txt   7856601

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ino-20250331.xsd EX-101.SCH 49730
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ino-20250331_cal.xml EX-101.CAL 60342
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ino-20250331_def.xml EX-101.DEF 244663
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ino-20250331_lab.xml EX-101.LAB 608753
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ino-20250331_pre.xml EX-101.PRE 424727
75 EXTRACTED XBRL INSTANCE DOCUMENT ino-20250331_htm.xml XML 846084
Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462
Business Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 8584103134
INOVIO PHARMACEUTICALS, INC. (Filer) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14888 | Film No.: 25939787
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)